Fundraising Fox

F-Prime Capital

also invests · investor profile

Boston, US · 3 known investors

Beam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases. The company focuses on therapeutic applications using single-letter DNA modifications.

BiotechDeep TechEnterprise SoftwareFoodTechMedical DevicesSaaS

Founders & leadership

JE
John EvansCEO

Investors · 3

F-Prime Capital✓ verifiedCambridge · $3M – $10M
ASTUTIA Ventures GmbHMünchen · $108K
Golden Sparrow Ventures, Llc$400K – $1M

Frequently asked questions

What does F-Prime Capital do?
Beam Therapeutics develops CRISPR base editing technology to create precision genetic medicines for treating human diseases. The company focuses on therapeutic applications using single-letter DNA modifications.
Who are F-Prime Capital's investors?
F-Prime Capital's investors include F-Prime Capital, ASTUTIA Ventures GmbH, Golden Sparrow Ventures, Llc.
Where is F-Prime Capital headquartered?
F-Prime Capital is headquartered in Boston, US.